Idiopátiás tüdőfibrózis: vizsgálatok itt: Dél-Korea
11 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Bucheon-si, Incheon, Seongnam-si, Seoul, Songpa-dong
- Életkor
- 40 év and over
- People
- 324 worldwide
- Run by
- Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00 - 2. fázisNot yet taking people in Dél-KoreaA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment
- Where
- Seoul
- Életkor
- 40 év and over
- People
- 70 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07926321 · EU 2026-527098-13-00 - 3. fázisNot yet taking people in Dél-KoreaLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Bucheon-si, Busan, Dong-gu, Ulsan, Goyang, Goyang-si, Haeundae-gu, Iksan, Kyunggi-do, Namdong-gu, Seoul, Suwon
- Életkor
- 18 év and over
- People
- 2380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Seongnam-si, Seoul
- Életkor
- 40 év and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - 3. fázisCsak meghívásosExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Where
- Incheon, Seongnam-si, Seoul
- Életkor
- 40 év and over
- People
- 1850 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT04905693 - 2. fázisTaking peopleA Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Where
- Bucheon-si, Busan, Gwangju, Seoul, Suwon
- Életkor
- 40 év and over
- People
- 240 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00 - 2. fázisTaking peopleStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Where
- Bucheon-si, Busan, Seongnam-si, Seoul
- Életkor
- 40 év and over
- People
- 165 worldwide
- Run by
- AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00 - 3. fázisTaking peopleStudy of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Where
- Incheon, Seongnam-si, Seoul
- Életkor
- 18 év and over
- People
- 698 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00 - 2. fázisTaking peopleSB17170 Phase 2 Trial in IPF Patients
- Where
- Goyang, Gwangmyeong, Seoul, Suwon
- Életkor
- 40 év and over
- People
- 30
- Run by
- SPARK Biopharma
See details and how to joinNCT06747923 - No phaseTaking peopleKorean Idiopathic Pulmonary Fibrosis Registry
- Where
- Seongnam-si
- Életkor
- 30 év to 100 év
- People
- 3000
- Run by
- Seoul National University Hospital
See details and how to joinNCT04160715 - No phaseTaking peopleControls for Respiratory Diseases
- Where
- Seoul
- Életkor
- 19 év to 90 év
- People
- 1572
- Run by
- Seoul National University Hospital
See details and how to joinNCT03120481